The company's expansion in the biological assay space aided by the data platform SAN FRANCISCO and KYIV, Ukraine, June 10, 2021 /PRNewswire/ -- Enamine, a leading provider of R&D Services as well as ...

Open-science research initiative, COVID Moonshot and the AI-driven Structure-enabled Antiviral Platform (ASAP) consortium, delivered a promising pre-clinical candidate 2,000 new compounds generated ...

Access to Enamine's novel compounds will allow Reaxys users to cut development times and costs by up to 90% London, United Kingdom--(Newsfile Corp. - December 3, 2024) - Elsevier, a global leader in ...

KYIV, Ukraine & SANKT AUGUSTIN, Germany--(BUSINESS WIRE)--The two leading experts in the exploration of ultra-large make-on-demand chemical spaces join forces to spark a new era of drug discovery.

Cresset, an innovative provider of integrated in silico solutions for drug discovery, announces an extension of the global collaboration with Enamine, the world’s leading chemical and biological ...

Enamine Ltd., a leading chemical research organization and producer of the world’s largest collections of novel building blocks (150,000) and screening compound libraries (2,400,000), and BioSolveIT ...

Screening libraries will leverage Recursion's MatchMaker tool to identify compounds across Enamine REAL Space predicted to bind to high-value targets. KYIV, Ukraine and SALT LAKE CITY, Dec. 20, 2023 ...

Enamine Ltd. and Danish biotech company Pcovery, have announced that they have extended their collaboration for the discovery of new drugs for the treatment of invasive fungal infections and platform ...

Kyiv, Ukraine and Salt Lake City, UT, April 09, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today announced ...

Enamine, a leading chemistry and R&D services company, today announced that it was a key synthetic chemistry contributor to a first-of-its-kind, open-science approach that led to the development of a ...